MYUNGMOON Pharm co.,Ltd Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4,227	5,836	4,392	7,962	4,858	6,813
Short-Term Investments	320	295	350	3,650	5,065	3,620
Trading Asset Securities	13.56	14.32	15.41	52.65	61.67	83.95
Cash & Short-Term Investments	4,560	6,145	4,758	11,664	9,984	10,517
Cash Growth	44.73%	29.17%	-59.21%	16.83%	-5.06%	-19.65%
Accounts Receivable	43,190	42,868	38,091	33,489	29,456	27,530
Other Receivables	3,418	3,670	4,044	4,243	3,606	2,171
Receivables	46,609	46,538	42,172	38,846	34,673	30,281
Inventory	41,241	38,724	32,685	30,280	25,660	26,032
Prepaid Expenses	240.18	118.66	210.07	189.83	184.71	504.29
Other Current Assets	762.88	546.14	505.1	455.72	205.58	132.32
Total Current Assets	93,413	92,072	80,329	81,436	70,707	67,466
Property, Plant & Equipment	166,716	165,856	161,994	140,196	141,777	142,861
Long-Term Investments	2,897	3,689	3,431	1,540	4,457	3,245
Other Intangible Assets	440.53	472.33	528.86	267.49	318.47	247.39
Long-Term Deferred Tax Assets	4,693	4,767	6,175	8,109	8,168	4,273
Other Long-Term Assets	5,465	5,291	5,222	5,001	5,022	5,170
Total Assets	273,932	272,455	257,988	236,549	230,450	223,263
Accounts Payable	18,069	15,379	17,382	16,746	15,677	13,633
Accrued Expenses	17,867	18,090	17,031	16,349	11,848	12,124
Short-Term Debt	50,664	51,106	42,114	74,607	73,503	75,657
Current Portion of Long-Term Debt	3,886	4,043	9,686	1,907	1,306	1,269
Current Portion of Leases	329	350.63	376.13	922.99	1,045	1,249
Current Income Taxes Payable	51.51	64.27	47.47	-	118.42	164.35
Other Current Liabilities	7,768	7,330	6,023	5,840	7,325	8,992
Total Current Liabilities	98,633	96,363	92,660	116,373	110,821	113,088
Long-Term Debt	42,448	42,646	35,255	12,584	6,092	4,957
Long-Term Leases	415.3	488.19	74.33	460.2	1,212	998.7
Pension & Post-Retirement Benefits	20,022	19,526	17,734	13,205	13,266	13,812
Long-Term Deferred Tax Liabilities	6,793	6,793	6,436	3,521	3,521	3,706
Other Long-Term Liabilities	2,217	2,182	2,707	1,652	270.67	827.67
Total Liabilities	170,529	167,999	154,865	147,794	135,182	137,389
Common Stock	16,977	16,977	16,977	16,977	16,977	16,977
Additional Paid-In Capital	35,178	35,178	35,178	35,178	35,178	77,313
Retained Earnings	2,156	2,976	564.41	6,031	11,425	-39,976
Treasury Stock	-1,471	-1,471	-1,471	-1,215	-540.01	-540.01
Comprehensive Income & Other	45,082	45,082	45,603	26,483	26,483	26,483
Total Common Equity	97,921	98,741	96,851	83,453	89,522	80,257
Minority Interest	5,482	5,716	6,271	5,302	5,745	5,617
Shareholders' Equity	103,403	104,457	103,123	88,755	95,267	85,874
Total Liabilities & Equity	273,932	272,455	257,988	236,549	230,450	223,263
Total Debt	97,742	98,634	87,505	90,482	83,157	84,130
Net Cash (Debt)	-93,182	-92,489	-82,748	-78,818	-73,173	-73,614
Net Cash Per Share	-2785.46	-2766.78	-2481.48	-2340.26	-2164.50	-2177.55
Filing Date Shares Outstanding	33.41	33.43	33.43	33.53	33.81	33.81
Total Common Shares Outstanding	33.41	33.43	33.43	33.53	33.81	33.81
Working Capital	-5,220	-4,291	-12,330	-34,937	-40,115	-45,622
Book Value Per Share	2931.15	2953.80	2897.28	2489.11	2648.13	2374.06
Tangible Book Value	97,481	98,268	96,322	83,186	89,204	80,010
Tangible Book Value Per Share	2917.96	2939.67	2881.46	2481.14	2638.71	2366.74
Land	100,264	100,264	100,264	74,397	74,397	74,726
Buildings	61,197	61,197	61,197	61,545	58,194	58,325
Machinery	35,960	34,682	33,266	32,325	30,828	29,991
Construction In Progress	8,870	8,402	2,191	2,191	3,418	2,365